Correlation Between MetLife and WuXi Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MetLife and WuXi Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MetLife and WuXi Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MetLife and WuXi Biologics, you can compare the effects of market volatilities on MetLife and WuXi Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MetLife with a short position of WuXi Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MetLife and WuXi Biologics.

Diversification Opportunities for MetLife and WuXi Biologics

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between MetLife and WuXi is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding MetLife and WuXi Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WuXi Biologics and MetLife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MetLife are associated (or correlated) with WuXi Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WuXi Biologics has no effect on the direction of MetLife i.e., MetLife and WuXi Biologics go up and down completely randomly.

Pair Corralation between MetLife and WuXi Biologics

Considering the 90-day investment horizon MetLife is expected to generate 0.26 times more return on investment than WuXi Biologics. However, MetLife is 3.92 times less risky than WuXi Biologics. It trades about 0.1 of its potential returns per unit of risk. WuXi Biologics is currently generating about -0.04 per unit of risk. If you would invest  5,977  in MetLife on September 4, 2024 and sell it today you would earn a total of  2,711  from holding MetLife or generate 45.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

MetLife  vs.  WuXi Biologics

 Performance 
       Timeline  
MetLife 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MetLife are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting technical and fundamental indicators, MetLife unveiled solid returns over the last few months and may actually be approaching a breakup point.
WuXi Biologics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in WuXi Biologics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental drivers, WuXi Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

MetLife and WuXi Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MetLife and WuXi Biologics

The main advantage of trading using opposite MetLife and WuXi Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MetLife position performs unexpectedly, WuXi Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WuXi Biologics will offset losses from the drop in WuXi Biologics' long position.
The idea behind MetLife and WuXi Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
FinTech Suite
Use AI to screen and filter profitable investment opportunities